Nicotinic modulation of therapeutic response in vitro and in vivo

International Journal of Cancer

Volumn 131, Issue 11, 2012, Pages 2519-2527

  Warren, Graham W ^a   Romano, Michelle A ^a   Kudrimoti, Mahesh R ^b   Randall, Marcus E ^b   McGarry, Ronald C ^b   Singh, Anurag K ^a   Rangnekar, Vivek M ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

chemoradiotherapy; hypoxia; hypoxia inducible factor 1 alpha (HIF 1 ); lung cancer; nicotine; radiotherapy; smoking; tobacco; xenograft

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CARBONATE DEHYDRATASE; CISPLATIN; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR XENOGRAFT;

ANIMALS; ANOXIA; CARBONIC ANHYDRASES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NICOTINE; PHOSPHATIDYLINOSITOL 3-KINASES; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867092944     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27556     Document Type: Article

References (24)

1. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW,. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003; 21: 1544-9.
2. Marin VP, Pytynia KB, Langstein HN, Dahlstrom KR, Wei Q, Sturgis EM,. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg 2008; 121: 451-7.
3. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN,. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328: 159-63.
4. Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP,. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 1997; 21: 497-509.
5. Treating tobacco use and dependence: 2008 update. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2008 May, 257.
6. Singh S, Pillai S, Chellappan S, Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol 2011; 2011: 456743.
7. Singh S, Pillai S, Chellappan S, Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. Epub 2011; March 30: 2011.
8. Dasgupta P, Chellappan SP,. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 2006; 5: 2324-8.
9. Warren GW, Rangnekar VM, McGarry R, Arnold SM, Kudrimoti M,. Pathways of resistance: potential effects of nicotine on cancer treatment response. Int J Radiat Oncol Biol Phys 2008; 72: S715.
10. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S,. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 2006; 103: 6332-7.
11. Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA,. Tobacco components stimulate Akt-dependent proliferation and NFkappa-B dependent survival in lung cancer cells. Carcinogenesis 2005; 26: 1182-95.
12. Xin M, Deng X,. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 2005; 280: 10781-9.
13. Onoda N, Nehmi A, Weiner D, Mujumdar S, Christen R, Los G,. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 2001; 23: 860-70.
14. Brahimi-Horn MC, Pouyssegur J,. HIF at a glance. J Cell Sci 2009; 122: 1055-7.
15. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris AL,. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002; 62: 2493-7.
16. Kappler M, Taubert H, Holzhausen HJ, Reddemann R, Rot S, Becker A, Kuhnt T, Dellas K, Dunst J, Vordermark D, Hänsgen G, Bache M,. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters. Strahlenther Onkol 2008; 184: 393-9.
17. Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, Maehara Y,. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer. J Thorac Oncol 2009; 4: 284-90.
18. Zhang Q, Tang X, Zhang ZF, Velikina R, Shi S, Le AD,. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007; 13: 4686-94.
19. Chintala S, Tóth K, Cao S, Durrani FA, Vaughan MM, Jensen RL, Rustum YM,. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol 2010; 66: 899-911.
20. Vaughan MM, Toth K, Chintala S, Rustum YM,. Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissues. Appl Immunohistochem Mol Morphol 2010; 18: 375-81.
21. Jin Z, Gao F, Flagg T, Deng X,. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem 2004; 279: 23837-44.
22. Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, et al. HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res 2011; 9: 259-70.
23. Vieira CA, de Paiva SA, Funai MN, Bergamaschi MM, Queiroz RH, Giglio JR,. Quantification of nicotine in commercial brand cigarettes: how much is inhaled by the smoker? Biochem Mol Biol Educ 2010 38: 330-4.
24. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.